RecruitingNCT07091344
This study is looking at whether a digital support tool can help people with Schizophrenia Disorders or Treatment Resistant Hallucinations. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Fundació Sant Joan de Déu
- Condition
- Schizophrenia
RecruitingNCT07144592
This study is comparing solution-oriented approach program with control group (No Intervention: Usual Care at Community Mental Health Center) for people with SCHIZOPHRENIA 1, Psychosocial Adaptation, or Treatment Adherence. Participants receive solution-oriented approach program or control group (No Intervention: Usual Care at Community Mental Health Center) and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Muş Alparslan University
- Condition
- Schizophrenia
RecruitingNCT05731414
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
RecruitingNCT07113119
This study is looking at whether Exercise intervention can help people with psychosis. Participants take part in Exercise intervention and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Greece
- Sponsor
- Aristotle University Of Thessaloniki
- Condition
- Schizophrenia
RecruitingNCT05748990
This study is looking at whether a digital support tool can help people with Schizophrenia or Healthy. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 17 Years to 45 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT04300946
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT03649581
This study is looking at compare two subforms of psychotic disorders that have been clinically distinguished in the 1970s for people with Schizophrenia. Taking part may give some people access to compare the two groups of schizophrenic patients, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT05929352
This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT05440214
This study is looking at whether Dialectical Behavior Therapy Skills Training can help people with Psychosis or Suicide. Participants take part in Dialectical Behavior Therapy Skills Training and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
RecruitingNCT02916810
This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT05550155
This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Caen
- Condition
- Schizophrenia
RecruitingNCT05617898
This study is looking at whether Motivational Interviewing can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
- Condition
- Schizophrenia
RecruitingNCT06740747
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Sham iTBS instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- Hannover Medical School
- Condition
- Schizophrenia
RecruitingNCT07060742
This study is looking at whether a digital support tool can help people with Psychosis, Exergaming, or Elderly. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 55 Years
- Countries
- Switzerland
- Sponsor
- Tobias Melcher
- Condition
- Schizophrenia
RecruitingNCT07056894
This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
RecruitingNCT06194344
This study is looking at whether Individualized imagery can help people with Psychosis. Participants take part in Individualized imagery and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT06058702
This study is comparing Delta-9-THC Very Low Dose with placebo for people with Schizophrenia or Cannabis Use Disorder. Participants receive Delta-9-THC Very Low Dose or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 21 Years to 60 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT05863572
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Uganda
- Sponsor
- George Washington University
- Condition
- Schizophrenia
RecruitingNCT06105151
This study is comparing VV119(SAD) with placebo for people with Schizophrenia. Participants receive VV119(SAD) or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Vigonvita Life Sciences
- Condition
- Schizophrenia
RecruitingNCT06961916
This study is looking at whether Active rTMS can help people with Schizophrenia. Participants take part in Active rTMS and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT04366518
This study is comparing Rivastigmine Transdermal System with placebo for people with Hallucinations, Auditory or Psychosis. Participants receive Rivastigmine Transdermal System or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT06888726
This study is comparing High-intensity transcranial alternating current stimulation (Hi-tACS) with control group for people with Schizophrenia, Negative Type, or Transcranial Alternating Current Stimulation. Participants receive High-intensity transcranial alternating current stimulation (Hi-tACS) or control group and complete study visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
RecruitingNCT07001878
This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 25 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
RecruitingNCT03781115
This study is comparing Ziprasidone with placebo for people with Schizophrenia. Participants receive Ziprasidone or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- University of Arizona
- Condition
- Schizophrenia
RecruitingNCT06126224
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Belgium, Canada, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Switzerland, Turkey, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia